Cargando…

Levels of pneumococcal conjugate vaccine coverage and indirect protection against invasive pneumococcal disease and pneumonia hospitalisations in Australia: An observational study

BACKGROUND: There is limited empiric evidence on the coverage of pneumococcal conjugate vaccines (PCVs) required to generate substantial indirect protection. We investigate the association between population PCV coverage and indirect protection against invasive pneumococcal disease (IPD) and pneumon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Jocelyn, Gidding, Heather F., Blyth, Christopher C., Fathima, Parveen, Jayasinghe, Sanjay, McIntyre, Peter B., Moore, Hannah C., Mulholland, Kim, Nguyen, Cattram D., Andrews, Ross, Russell, Fiona M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376256/ https://www.ncbi.nlm.nih.gov/pubmed/34343186 http://dx.doi.org/10.1371/journal.pmed.1003733

Ejemplares similares

Effectiveness of 7-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease in Medically At-Risk Children in Australia: A Record Linkage Study
por: Kabir, Alamgir, et al.
Publicado: (2022)

Population-based estimates of the effectiveness of pneumococcal vaccination in Australia
por: Gidding, Heather, et al.
Publicado: (2017)

Indirect effects of 13-valent pneumococcal conjugate vaccine on pneumococcal carriage in children hospitalised with acute respiratory infection despite heterogeneous vaccine coverage: an observational study in Lao People’s Democratic Republic
por: Chan, Jocelyn, et al.
Publicado: (2021)

Direct and indirect effects of 13-valent pneumococcal conjugate vaccine on pneumococcal carriage in children hospitalised with pneumonia from formal and informal settlements in Mongolia: an observational study
por: Chan, Jocelyn, et al.
Publicado: (2021)

Determining the pneumococcal conjugate vaccine coverage required for indirect protection against vaccine-type pneumococcal carriage in low and middle-income countries: a protocol for a prospective observational study
por: Chan, Jocelyn, et al.
Publicado: (2018)

Pneumococcal conjugate vaccination schedules in infants—acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study
por: Mackenzie, Grant A., et al.
Publicado: (2022)

Pneumococcal vaccination and childhood pneumonia in South Africa
por: Mulholland, Kim, et al.
Publicado: (2015)

Pneumonia hospitalisation and case-fatality rates in older Australians with and without risk factors for pneumococcal disease: implications for vaccine policy
por: Dirmesropian, S., et al.
Publicado: (2019)

Effectiveness of 13-valent pneumococcal conjugate vaccine against hypoxic pneumonia and hospitalisation in Eastern Highlands Province, Papua New Guinea: An observational cohort study
por: Blyth, Christopher C, et al.
Publicado: (2022)

Systematic Review of the Indirect Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Pneumococcal Disease and Colonization
por: Loo, Jennifer D., et al.
Publicado: (2014)

Indirect Effects of Pneumococcal Conjugate Vaccines in National Immunization Programs for Children on Adult Pneumococcal Disease
por: Kim, Young Keun, et al.
Publicado: (2016)

Pneumococcal Conjugate Vaccines Are Protective Against Respiratory Syncytial Virus Hospitalizations in Infants: A Population-Based Observational Study
por: Le, Huong, et al.
Publicado: (2023)

Indirect effect of 7-valent and 13-valent pneumococcal conjugated vaccines on pneumococcal pneumonia hospitalizations in elderly
por: Kislaya, Irina, et al.
Publicado: (2019)

Pneumococcal vaccine schedules (PVS) study: a cluster-randomised, non-inferiority trial of an alternative versus standard schedule for pneumococcal conjugate vaccination—statistical analysis plan
por: Mackenzie, Grant A., et al.
Publicado: (2022)

Association of Pneumococcal Conjugate Vaccine Coverage With Pneumococcal Meningitis: An Analysis of French Administrative Areas, 2001–2016
por: Alari, Anna, et al.
Publicado: (2019)

The Impact of Pneumococcal Conjugate Vaccine (PCV) Coverage Heterogeneities on the Changing Epidemiology of Invasive Pneumococcal Disease in Switzerland, 2005–2019
por: Oyewole, Oluwaseun Rume-Abiola, et al.
Publicado: (2021)

A reflection on invasive pneumococcal disease and pneumococcal conjugate vaccination coverage in children in Southern Europe (2009–2016)
por: Moreira, Marta, et al.
Publicado: (2016)

Indirect Effect of 7-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Carriage in Newborns in Rural Gambia: A Randomised Controlled Trial
por: Egere, Uzochukwu, et al.
Publicado: (2012)

Linking the Australian Childhood Immunisation Register to population-based perinatal datasets to assess coverage in at-risk groups
por: Moore, Hannah, et al.
Publicado: (2017)

Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young children
por: Nair, Harish, et al.
Publicado: (2016)

Using the Indirect Cohort Design to Estimate the Effectiveness of the Seven Valent Pneumococcal Conjugate Vaccine in England and Wales
por: Andrews, Nick, et al.
Publicado: (2011)

Impact of the introduction of pneumococcal conjugate vaccine on immunization coverage among infants
por: Lin, Nancy D, et al.
Publicado: (2005)

Poor Potential Coverage for 7-Valent Pneumococcal Conjugate Vaccine, Malawi
por: Gordon, Stephen B., et al.
Publicado: (2003)

Indirect costs of adult pneumococcal disease and the productivity-based rate of return to the 13-valent pneumococcal conjugate vaccine for adults in Turkey
por: Sevilla, J. P., et al.
Publicado: (2020)

Invasive Pneumococcal Disease after Routine Pneumococcal Conjugate Vaccination in Children, England and Wales
por: Ladhani, Shamez N., et al.
Publicado: (2013)

Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations
por: Naucler, Pontus, et al.
Publicado: (2017)

Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
por: Melegaro, Alessia, et al.
Publicado: (2010)

Factors associated with pneumococcal nasopharyngeal carriage: A systematic review
por: Neal, Eleanor Frances Georgina, et al.
Publicado: (2022)

Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands
por: van Deursen, Anna M.M., et al.
Publicado: (2012)

Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumococcal carriage in Fiji: results from four annual cross-sectional carriage surveys
por: Dunne, Eileen M, et al.
Publicado: (2018)

2706. Indirect Effects of Infant 13-valent Conjugate Pneumococcal Vaccination Program on Invasive Pneumococcal Disease in Adults in British Columbia, Canada
por: Vadlamudi, Nirma K, et al.
Publicado: (2019)

Effect of different schedules of ten-valent pneumococcal conjugate vaccine on pneumococcal carriage in Vietnamese infants: results from a randomised controlled trial
por: Smith-Vaughan, Heidi, et al.
Publicado: (2022)

Burden of Pneumococcal Disease in Northern Togo before the Introduction of Pneumococcal Conjugate Vaccine
por: Moïsi, Jennifer C., et al.
Publicado: (2017)

Pneumococcal vaccination in persons living with HIV: Pneumococcal conjugate, polysaccharide or both?
por: Dhingra, Bhavna, et al.
Publicado: (2020)

Direct and Indirect Impact of 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Invasive Pneumococcal Disease (IPD) Among Children and Adults in the U.S.
por: Pilishvili, Tamara, et al.
Publicado: (2017)

Effect of Age and Vaccination With a Pneumococcal Conjugate Vaccine on the Density of Pneumococcal Nasopharyngeal Carriage
por: Roca, A., et al.
Publicado: (2012)

Pneumococcal Conjugate Vaccination Followed by Pneumococcal Polysaccharide Vaccination in Lung Transplant Candidates and Recipients
por: Hoffman, Thijs W., et al.
Publicado: (2020)

Impact of Pneumococcal Conjugate Universal Routine Vaccination on Pneumococcal Disease in Italian Children
por: Fortunato, Francesca, et al.
Publicado: (2015)

Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Greenland
por: Nikolova, Kristiana Alexandrova, et al.
Publicado: (2021)

The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria
por: Adamu, Aishatu L., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r5m2mb8074f1da93i39fbc04k6